Dylan Graetz and Erica Kaye on qualitative research in oncology

The Lancet Oncology in conversation with

The Lancet Oncology in conversation with
Dylan Graetz and Erica Kaye on qualitative research in oncology
Feb 02, 2026
The Lancet Group

Jamie Prowse, Senior Editor at The Lancet Oncology, is joined by Dr Dylan Graetz (Department of Oncology and Department of Global Pediatric Medicine, St Jude Children’s Research Hospital) and Dr Erica Kaye (Department of Oncology, St Jude Children’s Research Hospital) to discuss qualitative in oncology.

Read the full Reviews:

https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00669-2 for The Power of Words: Evaluating the Role of Qualitative Methods in Cancer Research
and
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00670-9 for Expert Recommendations for the Conduct and Appraisal of Qualitative Research in Oncology

and the reviews in  Lancet Haematology 2026  https://doi.org/10.1016/S2352-3026(25)00321-7
and eClinicalMedicine https://doi.org/10.1016/j.eclinm.2025.103736

Tell us what you thought about this episode

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Episode Artwork Dylan Graetz and Erica Kaye on qualitative research in oncology 42:05 Episode Artwork Jesse Plascak and Marissa Baker on cancer mortality rates by occupation among US workers 22:54 Episode Artwork Andre Pfob and Peter Dubsky on The Lucerne Toolbox 3 25:41 Episode Artwork Gary Rodin on The human crisis in cancer: a Lancet Oncology Commission 10:46 Episode Artwork Matthias Preusser on the phase 2 TUXEDO-3 trial 17:10 Episode Artwork Andrea Necchi on TAR-200 plus cetrelimab as neoadjuvant therapy in patients with muscle-invasive bladder cancer 12:15 Episode Artwork Linda Bi, Ruchit Patel, Chloe Gui, Farshad Nassiri, and Matija Snuderl on TERT expression and TERT promoter mutations in meningiomas 14:22 Episode Artwork Jinming Li on patterns in genomic mutations among patients with early-onset colorectal cancer 7:36 Episode Artwork Abdalla Awidi on cancer control in the Middle East 8:22 Episode Artwork ASCO 2025 Debrief 14:45 Episode Artwork Caroline Robert on treatments for patients with advanced melanoma with BRAFV600E or BRAFV600K mutations (EBIN trial) 10:45 Episode Artwork Richard Bryant on transperineal vs transrectal biopsy for prostate cancer 18:02 Episode Artwork Professor Amar U. Kishan on HYpofractionateD RAdiotherapy for Prostate Cancer (HYDRA) 7:33 Episode Artwork Ariana Znaor on cancer surveillance in the Eastern Mediterranean region 20:03 Episode Artwork Ian Tannock on Common Sense Oncology principles for phase 3 randomised clinical trials 18:03 Episode Artwork Yannick Romero on the changing landscape of national cancer control plans 24:40 Episode Artwork M Saiful Huq and Mostafa Aziz Sumon on the series Cancer Care in South Asian Association for Regional Cooperation (SAARC) Countries 22:15 Episode Artwork Steven Horwitz on valemetostat for relapsed or refractory T-cell lymphoma 15:07 Episode Artwork Zachary Zumsteg on early phase trial design for novel drug-radiotherapy combination 17:21 Episode Artwork May Abdel-Wahab and Andrew Scott on The Lancet Oncology Commission on Radiotherapy and Theranostics 40:45 Episode Artwork Kanwal Raghav on trastuzumab deruxtecan in HER2-positive advanced colorectal cancer (DESTINY-CRC02) 13:22 Episode Artwork Emmy Boerrigter on dose selection of novel anticancer drugs 11:41 Episode Artwork Hisham Mehanna and Sue Yom on head and neck cancer consensus recommendations 36:56 Episode Artwork Garth Strohbehn and Katie Lichter on the environmental impact of cancer treatment 24:08 Episode Artwork James Shultz, Ana Patricia Ortiz, and Leticia Nogueira on cancer and compounding disasters in the Caribbean 35:05